跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Eprosenz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Eprosenz
Approved
STANDARD
Eprosenz
HK Bioinnovation Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5fed09a9b6b975bd
Company
HK Bioinnovation Co., Ltd
Type
Standard
Approval Details
Approval Id
5fed09a9b6b975bd
Drug Approval Philippines Name
Eprosenz
Product Name
Eprosenz
Registration Number
BRP-076-03
Brand Name
Eprosenz
Generic Name
Epoetin Alfa
Dosage Form
Solution For Injection (IV/SC)
Dosage Strength
4000 IU/0.5mL
Manufacturer
HK Bioinnovation Co., Ltd
Importer
H & B Pharma International Inc
Distributor
H & B Pharma International Inc
Issuance Date
29 March 2022
Expiry Date
23 August 2026
Pharmacologic Category
Hematopoietic Growth Factors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5fed09a9b6b975bd
Type
Standard
Back to Philippines FDA Approvals